Citizens! The FDA (Food and Drug Administration) needs your help! Earlier this week, the FDA published a notice in the federal register declaring that cannabidiol, aka CBD can be “beneficial” and guess what, they are looking for your opinion on the subject. What the FDA wants to know is how you have found it to be beneficial, and how you think the World Health Organization (WHO) should categorize it under the 1971 Convention on Psychotropic Substances. Other categories of interest are abuse potential, actual instances of abuse, trafficking, and “the impact of scheduling changes on the availability for medical use.”
The 1971 Convention on Psychotropic Substances is a UN resolution working to stop international drug trafficking among other things. Think of it like a global version of our own Controlled Substances Act, which is responsible for the creation of the scheduling system tha classified cannabis as one of the most dangerous drugs in the United States.
The FDA will be taking comments through September 13th, so there is still plenty of time for you to do your civic duty. They also want citizen’s thoughts on 16 other substances including Ketamine, Furanyl fentanyl, and Tramadol.
Here’s what the FDA had to say about CBD:
CBD has been shown to be beneficial in experimental models of several neurological disorders, including those of seizure and epilepsy. In the United States, CBD-containing products are in human clinical testing in three therapeutic areas, but no such products are approved by FDA for marketing for medical purposes in the United States. CBD is a Schedule I controlled substance under the CSA. At the 37th (2015) meeting of the ECDD, the committee requested that the Secretariat prepare relevant documentation to conduct pre-reviews for several substances, including CBD.
You can either submit electronic comments, or you can submit a paper (which I would recommend if you are very knowledgeable about CBD or have any kind of medical or scientific background). Follow the instructions for submissions here.
Source: Cannatech News
Image Source: herbalpassion.com
Will you be submitting any comments to the FDA? What will you say? Tell us below!